| Financial Year |
March 31 2023 |
| Monetary Funds |
656,263,166.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,134,160.17 |
| Accounts Receivable |
183,353,135.51 |
| Advances to Suppliers |
1,374,330.45 |
| Other Receivables |
441,519.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
89,338,936.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,986.11 |
| Total Current Assets |
1,009,569,914.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
160,134,753.85 |
| Under-construction Projects |
35,557,400.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,373,466.82 |
| R&D expenses |
-- |
| Goodwill |
3,238,201.98 |
| Long-Term Deferred and Prepaid Expenses |
433,042.18 |
| Deferred Income Tax Assets |
3,374,550.76 |
| Other Non-Current Assets |
28,277,154.62 |
| Sub-Total of Non-Current Assets |
282,388,570.53 |
| Total Assets |
1,291,958,484.98 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,665,492.95 |
| Accounts Payable |
85,200,916.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,857,553.42 |
| Taxes Payable |
5,595,055.94 |
| Interest Payable |
-- |
| Dividend Payable |
43,552,000.80 |
| Other payables |
45,922,778.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
15,321,576.79 |
| Sub-Total of Current Liabilities |
194,290,182.14 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,088,508.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,088,508.89 |
| Total Liabilities |
195,378,691.03 |
| Paid-In Capital(Or Share Stock) |
72,586,668.00 |
| Capital Surplus |
697,438,925.49 |
| Surplus Reserve |
39,866,129.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
286,323,639.64 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,096,579,793.95 |
| Owner's Equity（Stockholder's Equity） |
1,096,579,793.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,291,958,484.98 |
